Skip to main content
Gilberto Lopes Jr, MD, Oncology, Miami, FL, University of Miami Hospital

GilbertoDe LimaLopesJrMD

Oncology Miami, FL

Gastrointestinal Cancer, Thoracic Cancer

Physician

Dr. Lopes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lopes' full profile

Already have an account?

Summary

  • https://touch.www.linkedin.com/?sessionid=16989001089024&as=false&rs=false&can=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fin%2Fdrgilbertolopes&dl=no#profile/url=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fin%2Fdrgilbertolopes

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2003 - 2006
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1999 - 2003
  • Federal University of Rio Grande do Sul School of Medicine
    Federal University of Rio Grande do Sul School of MedicineClass of 1997
  • Bradford University
    Bradford UniversityMBA, business and economics of cancer care, with merit
  • Lee Kwan Yew School of Public Policy
    Lee Kwan Yew School of Public Policycertificate on health care management and policy

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2002 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Access to New and Expensive Medications in Developing Countries 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Press Mentions

  • New Hope for Patients with Advanced Lung Cancer
    New Hope for Patients with Advanced Lung CancerDecember 15th, 2022
  • New Hope for Advanced Lung Cancer Patients
    New Hope for Advanced Lung Cancer PatientsDecember 14th, 2022
  • Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNA
    Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNAJanuary 10th, 2022
  • Join now to see all

Hospital Affiliations